Vertex pursues parallel Hep C trials
November 01 2012
GlaxoSmithKline, Janssen sign on for mix-and-match trials for an all-oral hep C regimen.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.